Literature DB >> 2577722

Characterization of SSEA-1 glycolipids from the brain of a patient with fucosidosis.

G A Schwarting1, M A Williams, J E Evans, R H McCluer.   

Abstract

Neutral glycolipids from the brain of a patient with Fucosidosis were analyzed and two complex glycolipids containing five and eight sugars were isolated from the cortical grey matter. These two glycolipids reacted with antibodies recognizing the SSEA-1 [Le(x)(X)] carbohydrate determinant. SSEA-1 glycolipids are normally expressed in human embryonic brain but are found in only small amounts in postnatal human brain. The accumulation of the two SSEA-1 glycolipids in Fucosidosis brain thus represents a defect which affects the normal developmentally regulated decrease in postnatal expression of these glycolipids, and may be a contributing factor in the abnormal brain development associated with the disease. Chemical characterization of the two isolated glycolipids by gas chromatographic and mass spectrometric analyses has identified the two glycolipids as lacto-N-fucopentaosylceramide (III) and difucosyl-neolactonorhexaosylceramide.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2577722     DOI: 10.1007/bf01047849

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  17 in total

1.  Glycolipid stage-specific embryonic antigens (SSEA-1) in kidneys of male and female C57BL/6J and beige adult mice.

Authors:  M A Williams; S K Gross; J E Evans; R H McCluer
Journal:  J Lipid Res       Date:  1988-12       Impact factor: 5.922

2.  Oligosaccharide storage in brains from patients with fucosidosis, GM1-gangliosidosis and GM2-gangliosidosis (Sandhoff's disease).

Authors:  G C Tsay; G Dawson
Journal:  J Neurochem       Date:  1976-09       Impact factor: 5.372

Review 3.  Gangliosides: structure, isolation, and analysis.

Authors:  R W Ledeen; R K Yu
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

4.  The occurrence of III3-alpha-fucosyllactoneotetraosylceramide in human brain.

Authors:  M T Vanier; J E Månsson; L Svennerholm
Journal:  FEBS Lett       Date:  1980-03-24       Impact factor: 4.124

5.  Human and canine fucosidosis: a comparative lectin histochemistry study.

Authors:  J Alroy; A A Ucci; C D Warren
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

6.  The use of Sep-Pak C18 cartridges during the isolation of gangliosides.

Authors:  M A Williams; R H McCluer
Journal:  J Neurochem       Date:  1980-07       Impact factor: 5.372

7.  Structure of the accumulating oligosaccharide in fucosidosis.

Authors:  G C Tsay; G Dawson; S S Sung
Journal:  J Biol Chem       Date:  1976-10-10       Impact factor: 5.157

8.  Large alterations in ganglioside and neutral glycosphingolipid patterns in brains from cases with infantile neuronal ceroid lipofuscinosis/polyunsaturated fatty acid lipidosis.

Authors:  L Svennerholm; P Fredman; B Jungbjer; J E Månsson; B M Rynmark; K Boström; B Hagberg; L Norén; P Santavuori
Journal:  J Neurochem       Date:  1987-12       Impact factor: 5.372

9.  A new extended globoglycolipid carrying the stage specific embryonic antigen-1 (SSEA-1) determinant in mouse kidney.

Authors:  M Sekine; M Suzuki; F Inagaki; A Suzuki; T Yamakawa
Journal:  J Biochem       Date:  1987-03       Impact factor: 3.387

10.  Application of a simple methylation procedure for the analyses of glycosphingolipids.

Authors:  G Larson; H Karlsson; G C Hansson; W Pimlott
Journal:  Carbohydr Res       Date:  1987-04-01       Impact factor: 2.104

View more
  2 in total

1.  alpha1,3 Fucosyltransferase, alpha-L-fucosidase, alpha-D-galactosidase, beta-D-galactosidase, and Le(x) glycoconjugates in developing rat brain.

Authors:  G Y Wiederschain; O Koul; J M Aucoin; F I Smith; R H McCluer
Journal:  Glycoconj J       Date:  1998-04       Impact factor: 2.916

2.  Expression of neolactoglycolipids: sialosyl-, disialosyl-, O-acetyldisialosyl- and fucosyl- derivatives of neolactotetraosyl ceramide and neolactohexaosyl ceramide in the developing cerebral cortex and cerebellum.

Authors:  D K Chou; Y Suzuki; F B Jungalwala
Journal:  Glycoconj J       Date:  1996-04       Impact factor: 2.916

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.